Unlocking the Power of Real-World Data in Rare Disease Research
I recently had the opportunity to sit down with Danny Levine for an episode of his RARECast podcast to discuss something I’m deeply passionate about: how real-world data (RWD) is transforming the landscape of rare disease research. As someone who has spent my...
Breaking Down the Language Barrier in Real-World Data
Access to real-world data (RWD) is no longer the challenge; our ability to interact with it is. The barrier lies in the friction between researchers and the systems designed to unlock RWD’s potential. Unless we remove that friction, the promise of faster, smarter,...
Unlocking the Future of Clinical Trials: Real-World Data, AI, and the Road to 2050
When we think about the future of clinical research, it’s easy to picture gleaming technology, seamless data flows, and a world where trials are faster, smarter, and more inclusive. But let’s be honest. We’re not there yet. That’s exactly the conversation I had in...
TriNetX LIVE™ Named Best of Show Finalist at SCOPE Europe: Transforming Clinical Trial Site Selection Through Data-Driven Intelligence
The clinical trial industry faces a persistent and costly challenge: poor site selection. With up to 85% of trials failing to meet enrollment targets due in part to suboptimal site identification, the path from promising therapeutic concept to patient access remains...
Artificial Intelligence and Real-World Data: The Duo That’s Reshaping Drug Development
In today’s era of exponential data growth, real-world data (RWD) is abundant, but its value hinges on our ability to interpret it with speed, scale, and precision. That’s where artificial intelligence (AI) comes into play. At TriNetX, we’re seeing firsthand how the...
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE Mass., October 15, 2025 — TriNetX, driven by its vision of a connected world where data and...
Overcoming AI Risk and Inertia to Build Data-Driven Clinical Trials of Tomorrow
Clinical research is at a crossroads. The technology exists, the data is available, and the ambition is clear, but adoption of truly integrating Artificial Intelligence (AI) and data-driven trials often stalls due to risk, trust, and organizational inertia. In this...
Clinical Trial Representativeness: Sanofi’s Dr. Monique Adams on Real-World Data and Inclusive Research
As I sat down with Dr. Monique Adams of Sanofi for our most recent episode of The Future Prescription: Inside the Trends vodcast, I was reminded just how critical it is to move conversations about representativeness in clinical trials from aspiration to action....